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RNA exosome mutations in pontocerebellar hypoplasia
alter ribosome biogenesis and p53 levels
Juliane S Müller1,2,*, David T Burns1,3,*, Helen Griffin1,* , Graeme R Wells3, Romance A Zendah3 , Benjamin Munro1,2 ,
Claudia Schneider3,* , Rita Horvath1,2,*
The RNA exosome is a ubiquitously expressed complex of nine
core proteins (EXOSC1-9) and associated nucleases responsible
for RNA processing and degradation. Mutations in EXOSC3,
EXOSC8, EXOSC9, and the exosome cofactor RBM7 cause ponto-
cerebellar hypoplasia and motor neuronopathy. We investigated
the consequences of exosomemutations on RNA metabolism and
cellular survival in zebrafish and human cell models. We observed
that levels of mRNAs encoding p53 and ribosome biogenesis
factors are increased in zebrafish lines with homozygous muta-
tions of exosc8 or exosc9, respectively. Consistent with higher p53
levels, mutant zebrafish have a reduced head size, smaller brain,
and cerebellum caused by an increased number of apoptotic cells
during development. Down-regulation of EXOSC8 and EXOSC9 in
human cells leads to p53 protein stabilisation and G2/M cell cycle
arrest. Increased p53 transcript levels were also observed in
muscle samples from patients with EXOSC9 mutations. Our work
provides explanation for the pathogenesis of exosome-related
disorders and highlights the link between exosome function,
ribosome biogenesis, and p53-dependent signalling. We suggest
that exosome-related disorders could be classified as
ribosomopathies.
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Introduction
The core of the eukaryotic RNA exosome is composed of nine protein
subunits (EXOSC1–EXOSC9 in Metazoa) and forms a two-layered ring,
through which substrate RNAs can pass (Mitchell et al, 1997; Liu et al,
2006; Bonneau et al, 2009). The upper ring, the so-called cap of the
exosome, is composed of EXOSC1-3 and the lower hexameric ring, or
barrel of the exosome, is formed by EXOSC4-9. Catalytic activity of the
human exosome is provided by the loosely associated EXOSC10/RRP6,
DIS3/RRP44, or DIS3-like ribonucleases (Staals et al, 2010; Tomecki et al,
2010; Sloan et al, 2012). In the nucleus, the exosome processes and
degrades a wide range of precursor RNAs, un-spliced pre-messenger
RNAs, and cryptic transcripts (Allmang et al, 1999; Bousquet-Antonelli
et al, 2000; Kadaba et al, 2004; Wyers et al, 2005; Gudipati et al, 2012;
Sayani & Chanfreau, 2012; Schneider et al, 2012a; Schneider & Tollervey,
2013). Some reported that in the cytoplasm, the exosome degrades
mRNAs that contain AU-rich elements (AREs) and RNAs that have
evaded degradation in the nucleus (van Hoof et al, 2000; Mukherjee et
al, 2002); however, no new evidence is available to corroborate this.
Recessive mutations in EXOSC3, EXOSC8, and EXOSC9 have been
associated with variable combinations of pontocerebellar hypoplasia
(PCH) and spinalmotor neurondysfunction (Pontocerebellar hypoplasia
type 1B, OMIM # 614678; Pontocerebellar hypoplasia type 1C, OMIM
#616081; and Pontocerebellar hypoplasia type 1D, OMIM # 618065) and
with central nervous system demyelination in patients carrying muta-
tions in EXOSC8 (Wan et al, 2012; Boczonadi et al, 2014; Muller et al, 2015;
Burns et al, 2018; Morton et al, 2018). Bi-allelic EXOSC2mutations cause a
usually milder and more complex genetic syndrome with short stature,
dysmorphic features, myopia, retinitis pigmentosa, progressive senso-
rineural hearing loss, hypothyroidism, premature ageing, and mild in-
tellectual disability (Di Donato et al, 2016; Yang et al, 2019). A spinal
muscular atrophy-like phenotype has been reported in a patient with a
homozygous mutation in RBM7, another protein interacting with the
exosome (Giunta et al, 2016).
Importantly, an intact RNA exosome is critical for the assembly of the
ribosome, the essential RNA–protein machinery that synthesises all
cellular proteins (Tafforeauet al, 2013; Sloanet al, 2013b, 2014; Gillespie et
al, 2017). Defects in human ribosome production have been linked to
more than 20 genetic diseases (“ribosomopathies”) and can cause
stabilisation of the tumour suppressor p53, leading to cell cycle arrest
and apoptosis (Sloan et al, 2013a; Pelava et al, 2016; Aubert et al, 2018;
Yang et al, 2018).
In patient fibroblasts, most reported core exosome–associated mu-
tations result in reduced protein (Boczonadi et al, 2014; Burns et al, 2018).
Reduction of single core exosome subunits impairs the assembly of the
whole complex (Burns et al, 2018), which is likely to lead to the improper
processing and degradation of RNA. Transcriptome-wide studies in-
vestigated the effect ofmutations in the human exosome–associated
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nucleases DIS3 and RRP6 (Szczepinska et al, 2015; Davidson et al,
2019), but it is still unclear which genes and species of RNA are most
affected by mutations that are predicted to lead to a reduction in the
core exosome complex in vivo. Discovering RNA types, which are
perturbed by the abnormal function of the exosome could elucidate
the mechanism behind core exosome–associated diseases and may
identify potential novel molecular targets.
Gene knockdown via morpholino oligonucleotides targeting exosc3,
exosc8, and exosc9 has successfully recapitulated the patient phe-
notype in zebrafish. Knockdown of these genes in zebrafish resulted in
cerebellar hypoplasia and muscle weakness likely due to failure of
motor axons to migrate to neuromuscular junctions (Wan et al, 2012;
Boczonadi et al, 2014; Burns et al, 2018). However, morpholino
knockdown is transient and can sometimes produce off-target effects
with varying severity of phenotypes (Kok et al, 2015; Stainier et al, 2015).
Previously, we studied transcript profiles in fibroblasts from
patients with mutations in EXOSC8, EXOSC9, and the exosome cofactor
RBM7, as well as in zebrafish where the expression of these genes was
down-regulated via the injection of antisense morpholinos (Boczonadi
et al, 2014; Giunta et al, 2016; Burns et al, 2018). In our previous work, we
specifically selected poly(A)-tailed RNA for analysis by RNA sequencing
and focused mainly on the cytoplasmic function of the exosome in-
volving the degradation of AU-rich mRNA. However, we also detected a
significant number of long non-coding RNAs among the differentially
expressed transcripts (e.g., HOTAIR) (Giunta et al, 2016) and noticed cell
line–specific differences in the poly(A)–tailed transcript profiles in pa-
tient fibroblasts depending on the gene defect. PCH subforms (with
mutations in the tRNA-splicing endonuclease complex [TSEN], the
cleavage and polyadenylation factor I subunit [CLP1], or the target of
EGR1 protein 1 [TOE1]) have all been linked to changes in overall RNA
metabolism, characterised by processing defects of small non-coding
RNAs such as tRNAs and small nuclear RNAs (snRNAs) (Buddeet al, 2008;
Karaca et al, 2014; Schaffer et al, 2014; Breuss et al, 2016; Lardelli et al,
2017). The RNA exosome is known to be involved in processing and
degradation of many, if not all, long and small non-coding RNA species
in yeast and higher eukaryotes, which includes the precursors to the
mature ribosomal RNAs (rRNAs) as well as small nuclear and nucleolar
RNAs (sn[o]RNAs) (Gudipati et al, 2012; Schneider et al, 2012a; Szczepinska
et al, 2015; Tomecki et al, 2017).
Here, we therefore use CRISPR/Cas9 to generate a stable line of
zebrafish with mutations in exosc8 and exosc9, allowing us to generate
large numbers of homozygous mutants with a homogenous phenotype,
andstudied the impactof exosomedisruptionon zebrafishdevelopment,
RNA metabolism, and cellular survival in the mutant fish. In parallel, we
also performed siRNA-mediated down-regulation of EXOSC8 and EXOSC9
in human cells to look at exosome deficiency in the mammalian system.
Results
RNA analysis in homozygous exosc8 and exosc9 mutant zebrafish
reveals increased mRNA levels of factors involved in ribosome
assembly and other RNA metabolism pathways
To obtain a stable in vivo model of PCH, we created mutant
zebrafish lines using CRISPR/Cas9 (Fig 1). We selected zebrafish that
were heterozygous for the frameshift mutation c.26_27del in exosc8
(NM_001002865:exon2:c.26_27del:p.E9fs) and c.198_208del in exosc9
(NM_001006077:exon3:c.198_208del:p.K67fs) (Fig S1). Heterozygous
zebrafish were crossed, and embryos were allowed to develop to 5
days post-fertilisation (dpf). At 5 dpf, ~25% of embryos in each
clutch appeared to have smaller heads and eyes and were unable
to inflate their swim bladder (Fig 1A). Homozygous mutant larvae
died between 5 and 7 dpf; all further analyses were performed at 5
dpf before their death. This phenotype was consistent with what
was previously seen with morpholino oligos targeting exosc3,
exosc8, and exosc9 (Wan et al, 2012; Boczonadi et al, 2014; Burns et
al, 2018).
PCR and sequencing confirmed that the abnormal zebrafish were
homozygous for exosc8 (c.26_27del) and exosc9 (c.198_208del)
mutations, respectively (Fig S1A–D). Heterozygous mutation carriers
appeared phenotypically normal (data not shown). Although we
were not able to confirm the loss of exosc8 or exosc9 on a protein
level in the homozygous mutants because of the lack of a suitable
antibody, we assume that very little or no functional protein was
synthesised in the homozygous animals.
We performed RNAseq analysis on total RNA to see if there were
abnormalities in the RNA profiles of the homozygous mutant
zebrafish. The RNAseq analysis revealed that there was little re-
duction in the levels of the exosc8 mRNA in the exosc8 mutants
(log2fold change in RNAseq analysis of −0.052), which was surprising
given that the c.26_27del mutation would be predicted to trigger
mRNA degradation via nonsense-mediated decay, but it might be
that exosome deficiency leads to reduced nonsense-mediated
decay. The exosc9 mRNA, however, was reduced to about 50% of
the wild-type levels in the exosc9 mutants in the RNAseq analysis
(log2fold change = −0.865). A reduction was also indicated by RT-PCR
(non-quantitative PCR, Fig S1E).
Published RNAseq data from 3-dpf-old zebrafish embryos were
available for comparison, where the expression of exosc3 was
down-regulated via antisense morpholino oligonucleotide injec-
tion targeting the start codon of exosc3 and blocking exosc3
translation (Francois-Moutal et al, 2018). 185 protein-coding tran-
scripts were significantly increased in both mutants and the exosc3
morphants, including eight transcripts that showed greater than
twofold increase in steady-state levels in all mutants. The exosc3
morphants, however, had a more severe phenotype than our
mutants, possibly because of the fact that translation-blocking
morpholinos also target the maternally deposited mRNA, not
only the RNA transcribed by the embryo. This might have reduced
the number of common transcripts. Somewhat surprisingly, given
that the RNA exosome is an RNA decay/processing machine, 333
transcripts were significantly decreased with 26 transcripts showing
a greater than twofold decrease in all mutants than in control
embryos. This is mainly driven by a higher number of decreased
transcripts in the exosc8 mutant fish (Fig S2). Exosome dysfunction
might cause a negative feedback loop on transcription levels.
Over-representation analysis of protein-coding genes that were
significantly increased in homozygous mutant exosc8 and exosc9
zebrafish embryos and the exosc3 morphants compared with
controls showed higher levels of RNAs in gene ontology (GO) terms
associated with ribosome assembly, snoRNP/Small Cajal body
specific RNP (scaRNP) complexes, and (t)RNA modifications (Figs
2A, S2, and Table S1). Although 70 of the 185 significantly increased
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transcripts were associated with the general “RNA metabolic
process” GO term, a remarkable 90% of those (63 out of the 70
transcripts, Table S2) were found to belong to the pathway of ri-
bosome biogenesis and 51 of the 70 more precisely to the rRNA
processing pathway (Fig 2B, http://pantherdb.org/).
In addition to changes in protein-coding transcripts, there was
also a greater than twofold increase in normalised RNA read counts
for 182 (9.0%) and 153 (7.6%) of 2,004 individual non-coding RNAs in
the exosc8 and exosc9 homozygous mutant zebrafish, respectively,
compared with wild-type and heterozygous clutchmates (Fig 2C–E,
selected non-coding RNAs represented in Fig S2). In contrast, 111
(5.5%) and 80 (4.0%) non-coding RNAs surprisingly showed a
greater than twofold decrease than controls (Table S3). Overall,
there was a significant increase in all non-coding RNA reads in
exosc8 embryos versus controls (t = 2.8653, P-value = 0.004), par-
ticularly RNAs belonging to the cytosolic tRNA, miscRNA (miscel-
laneous other RNAs that do not fall in any of the other categories),
and small Cajal body–specific RNA (scaRNA) categories (Fig 2C). A
Figure 1. exosc8 and exosc9 homozygous mutant
zebrafish develop microcephaly.
(A) Gross anatomy of 5-dpf wild-type, exosc8
homozygous mutant and exosc9 homozygous mutant
zebrafish embryos; lateral view, anterior to the left.
Scale bar: 500 μm. (B) Dorsal view of wild-type, exosc8
homozygous mutant and exosc9 homozygous mutant
zebrafish embryos. Scale bar: 500 μm. (C, D, E)
Standard length, (D) area of eyes, and (E) area of head
in 5-dpf wild-type, exosc8 homozygous mutant and
exosc9 homozygous mutant zebrafish embryos. 13
control, 8 exosc8 (c.26_27del), and 5 exosc9
(c.198_208del) homozygous larvae were measured for
the quantification. Error bars represent the standard
error (±SEM), and statistical analysis was performed
using unpaired t tests (exosc8 versus wt and exosc9
versus wt, respectively). NS, not significant.
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comparison of the per gene log2 ratios of non-coding read counts
showed an overall positive correlation between exosc8 and exosc9
embryos at the individual gene level for all RNA categories (Fig 2C
and D).
Altered mRNA levels of apoptosis-related genes are consistent
with an increased number of apoptotic cells in the head of exosc8
and exosc9 zebrafish mutants
In addition to pathways linked to ribosome biogenesis or RNA
metabolism, there was a significant increase in RNA counts from six
genes (TP53, RPS27L, BAX, RRN3, MYBBP1A, and MDM2) from the GO
term “intrinsic apoptotic signalling by p53 class mediator” (GO:
0072332, qvalue = 0.001, Fig 2A). This was interesting, given that,
although an intact exosome is essential for ribosome biogenesis,
defects in ribosome production have been shown to cause sta-
bilisation of the tumour suppressor p53, via inhibition of MDM2,
leading to cell cycle arrest and apoptosis (Sloan et al, 2013a; Pelava
et al, 2016; Aubert et al, 2018). The increase in mdm2 transcript was
2.3 fold and 2.56 fold, respectively, in the exosc8 and exosc9 ho-
mozygous mutant embryos and in p53 transcript 2.69 fold and 2.44
fold, respectively (Fig 2F). The increase in p53 mRNA levels, but not
in mdm2 mRNA levels, was confirmed via qRT-PCR (Fig 2G).
Although there was no significant difference in the standard
length of zebrafish larvae at 5 dpf (Fig 1C), exosc8 and exosc9 homo-
zygous mutant zebrafish had significantly smaller eyes and heads (Fig
1B, D, and E). In addition, both the exosc8 and exosc9 homozygous
embryos had a significantly smaller midbrain (Fig 3A and B) and cer-
ebellum (Fig 3A and C) than WT and heterozygous clutchmates, fewer
motor axonbranches (Fig S3) at 5 dpf, and thinner tailswithdisorganized
skeletal muscle fibres (Fig S4).
As the exosc8 and exosc9 homozygous mutants had noticeably
smaller heads and eyes, cerebellar atrophy, and significant up-regulation
of transcripts from the p53-dependent signalling pathway, we performed
acridine orange staining to see if we can detect an increase in apoptosis
in themutant zebrafish embryos. Indeed, in the heads of the exosc8 and
exosc9 homozygous mutant zebrafish embryos, there appeared to be a
pronounced increase in apoptosis at 48 hours post-fertilisation (hpf) (Fig
4A); quantification of apoptotic cells (=acridine orange positive spots)
showed a significant increase in homozygous mutants compared with
wild-type and heterozygous embryos (Fig 4B). This increase in apoptosis
would lead toa reduction in thenumberof cells in theheadandcouldbe
the cause of the observed microcephaly and cerebellar hypoplasia or
atrophyobserved in the exosc8and exosc9homozygousmutant embryos
at 5 dpf (Figs 1 and 3).
We had access to and have previously published RNAseq data
from muscle biopsies of two patients with EXOSC9 mutations (Burns
et al, 2018). Analysis showed significant changes in expression of a large
number of genes: 2,778 geneswere significantly up-regulated and 2,864
down-regulated in both individuals (Table S4), among them transcripts
originating from genes linked to motor neuronopathy, familiar
amyotrophic lateral sclerosis, or distal arthrogryposis. In addition,
several pathways linked to p53 (such as DNA damage response, signal
transduction by p53 class mediator, and intrinsic apoptotic signalling
pathway by p53 class mediator) and genes encoding components of
the large ribosomal subunit were also significantly increased (Table
S4). This confirms that core exosome deficiency directly affects p53-
dependent signalling also in patient tissues.
RNAi-mediated down-regulation of core exosome subunits in
cultured human cells leads to a significant increase in p53 protein
levels and a G2/M cell cycle arrest
To investigate the effect of core exosome disruption on the p53-
dependent signalling pathway in more detail and on a protein level,
HCT116 cells (a human colorectal cancer cell line) were treated with a
siRNA targeting the EXOSC8 or EXOSC9mRNA or a control siRNA targeting
firefly luciferase.Westernblot analysis of total proteinextract fromsiRNA-
treated cells confirmed EXOSC8 or EXOSC9 protein depletion upon
treatment with their target siRNA (Fig 5A, left panel). In addition, siRNA-
mediated depletion of EXOSC8 or EXOSC9 also significantly reduced
EXOSC9 or EXOSC8 protein levels, respectively. This finding is in agree-
ment with previous studies, in which reduction of single core exosome
subunits impaired the assembly of the whole complex (Burns et al, 2018).
Importantly, down-regulation of both core exosome subunits by RNAi
resulted in a ~1.7 fold (EXOSC8) or ~2.5 fold (EXOSC9) statistically signif-
icant increase in p53 protein levels (Fig 5A, right panel). These data are
consistent with the high p53 mRNA levels observed in exosc8−/− and
exosc9−/− homozygous zebrafish (Fig 2F and G) and could reflect in-
creased stability and/or higher translation rate of the p53 mRNA in
HCT116 cells in the absence of an intact core exosome.
However, it is also important to note that RNAi-mediated depletion
ofEXOSC8and EXOSC9haspreviously beenshown to causeadefect in the
processing of rRNA in cultured cells (Tafforeau et al, 2013), and p53 protein
stability is directly linked to ribosome production (reviewed in Pelava et al
[2016]). Defects in ribosome biogenesis cause accumulation of the 5S RNP,
a large subunit ribosomeassembly intermediatecomposedof the5S rRNA
and two ribosomal proteins (RPL5 and RPL11). The 5S RNP regulates p53
protein levelsbybinding toand inhibitionof theE3ubiquitinprotein ligase
MDM2, which targets p53 for degradation (Sloan et al, 2013b).
Figure 2. exosc8 and exosc9 homozygous mutant zebrafish have increased non-coding RNA expression and differences in gene expression.
Summary of RNAseq performed on 5-dpf wild-type, exosc8 homozygous mutant and exosc9 homozygous mutant zebrafish embryos. (A) Gene set over-representation
analysis of RNAs that were significantly increased or decreased in both homozygous mutant exosc8 and exosc9 zebrafish embryos compared with controls. (B) Selected
GO terms and number of transcripts associated with them among the increased protein-coding RNAs in the mutant zebrafish lines. GO term analysis was performed on
http://pantherdb.org/. (C) Log2 ratios of cumulative, normalised RNA read counts for different non-coding RNA types in exosc8 or exosc9 homozygous mutant embryos
versus controls. (D) Correlation of exosc8 and exosc9 log2 ratios of cumulative, normalised read counts for individual non-coding RNA genes. (E) Volcano plot showing the
differential expression of transcripts in exosc8 and exosc9 homozygous mutants versus controls, with statistical significance (P-value) on the y-axis versus the magnitude
of change (fold change) on the x-axis. (F) SelectedmRNAs where increased levels were observed in eoxsc8 and exosc9 homozygousmutant zebrafish. (F, G) Validation of
changes in gene expression via qRT-PCR for the mRNAs represented in (F). Error bars represent the standard error (±SEM), and statistical analysis was performed using
unpaired t tests (exosc8 versus wt and exosc9 versus wt, respectively). Values have been normalised to a housekeeping gene and to wt fish; wt level has been set to one and
is represented by the dotted line. *P-value < 0.05, **P-value < 0.01, NS, not significant.
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We therefore considered that stabilisation of the p53 protein
caused by a defect in ribosome production may also strongly
contribute to the higher p53 protein levels seen upon EXOSC9
knockdown (Fig 5A), likely in addition to the proposed increased
stability of the p53 mRNA. To test this hypothesis, siRNA-mediated
depletion of EXOSC9 was performed in conjunction with depletion
of the 5S RNP component RPL5. Depletion of both EXOSC9 and RPL5
in HCT116 cells did not lead to increased levels of p53 protein
compared with treatment with a control siRNA, and p53 protein levels
were significantly reduced upon double depletion compared with
depletion of EXOSC9 alone (Fig 5B). Given that RPL5 depletion is not
expected to directly affect p53 mRNA stability, these data indicate a
5S RNP-dependent stabilisation of the p53 protein due to a ribosome
biogenesis defect occurring upon EXOSC9 depletion in HCT116 cells.
To further determine whether siRNA-mediated down-regulation
of EXOSC9 and the resultant increase in p53 protein levels affect the cell
cycle, propidium iodide (PI) DNA staining of HCT116 cells was performed
in combinationwithflowcytometry (Fig 5CandD). Cellswere treatedwith
a control siRNA or a siRNA targeting EXOSC9 mRNA for ~60 h before
staining and FACS analysis (using a FACS Canto II flow cytometer and
FACSDIVA software [BDBiosciences]). Treatmentwith 4nMactinomycinD
(ActD), a chemotherapeutic agent known to block rRNA synthesis by
inhibiting RNA polymerase I, was used as a positive control, as it has
been shown previously to cause increased p53 levels (~4 fold) as well as
a G1 and G2/M cell cycle arrest (Fumagalli et al, 2012; Sloan et al, 2013a).
Analysis of the FACS data showed that treatment with 4 nM ActD
for 18 h caused a significant G1 and G2/M cell cycle arrest, as well as
a significant reduction in the S phase, compared with untreated
control HCT116 cells (Fig 5C and D). Depletion of EXOSC9 also caused
a significant G2/M cell cycle arrest together with a decrease of cells
in the G0/G1 phase, consistent with its effect on p53 protein levels
(Fig 5C and D) but did not change the distribution of cells in the S
phase of the cell cycle. The phenotype observed upon EXOSC9
depletion is therefore reminiscent of the nucleolar stress response
(Yang et al, 2018) and similar, but milder than, the cell cycle defect
observed upon treatment with ActD.
Transcriptome analysis in exosome patient cells
As HCT116 cells are a cancer cell line, we also wanted to study
changes on transcript levels and the p53 pathway in neuronal cells
Figure 3. exosc8 and exosc9 homozygous mutant
zebrafish develop cerebellar atrophy.
(A) Immunofluorescence in 5-dpf wild-type, exosc8
homozygous mutant and exosc9 homozygous mutant
zebrafish embryos with antibodies raised against
HuC (green) and Pvalb7 (red) Pvalb7 is a marker for
Purkinje cells in the cerebellum, HuC is an early
neuronal marker. Scale bar: 500 μm. (B, C)
Quantification of (B) HuC-positive area and (C) Pvalb7-
positive area in 5-dpf wild-type, exosc8 homozygous
mutant and exosc9 homozygous mutant zebrafish
embryos. Three control, six exosc8 (c.26_27del), and six
exosc9 (c.198_208del) homozygous larvae were
measured for the HuC quantification. 6 control, 7
exosc8 (c.26_27del), and 11 exosc9 (c.198_208del)
homozygous larvae were measured for the Pvalb7
quantification. Error bars represent the standard
error (±SEM) and statistical analysis was performed
using unpaired t tests (exosc8 versus wt and exosc9
versus wt, respectively). Labelling: C, cerebellum; F,
forebrain; H, hindbrain and spinal cord; M, midbrain.
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originating from patients with exosome mutations. We collected
fibroblasts from patients carrying the EXOSC3 mutation p.Gly31Ala,
the EXOSC8 mutation p.Ala2Val, and the EXOSC9 mutation p.Leu14Pro,
respectively. We reprogrammed the fibroblasts into induced neuronal
progenitor cells (iNPCs), thus creating a cell culture model which is more
closely related to the affected nervous system (Fig S5). All three iNPC lines
showed a small overall increase in total non-coding RNA sequence read
counts compared with control iNPC lines, which were derived from fi-
broblasts taken fromhealthy, but genetically non-related individuals,with
different distributions in themagnitude of RNA alteration per non-coding
RNA category for each cell line (Figs 6A, S6, S7, and Table S5). The EXOSC8
iNPCs showed an increase in total RNA read counts for all individual
categories of non-coding RNAs, with the largest increase (+1.3 log2) seen
with snoRNAs, and also substantial increases in miRNA (+0.7 log2), tRNA
(+0.5 log2), and snRNA (+0.3 log2) categories. The EXOSC3 cell line also
showed an increase in snoRNAs (+0.6 log2); however, this increase was
absent from the EXOSC9 cell line that overall showed a small decrease
(−0.2 log2) in snoRNAs. ScaRNA levels arealso slightly increased inall three
iNPC lines. The differential expression of the different categories of non-
coding RNA matches our findings from the zebrafish mutants.
In the EXOSC8 iNPCs, gene set over-representation analysis of
the 321 and 220 RNAs that were significantly increased or decreased
in the mutant iNPCs compared with controls revealed an up-
regulation of the ER unfolded protein response and ER–Golgi in-
termediate compartment, as well as factors linked to intrinsic
apoptotic signalling due to ER stress (Figs 6B, S8, and Table S6). A
few differentially expressed genes (Fig 6C, individual plots Fig S8)
have been shown to play a role in development. We found in-
creased levels of chordin (CHRD), a gene implicated in organising
the early development of the mammalian head (Anderson et al,
2002), and decreased levels of calbindin 1 (CALB1), a gene asso-
ciated with Cerebellar Disease and Purkinje Cells (Vig et al, 2012).
The EXOSC8 iNPCs also showed a slight overall increase in the levels
of AU-rich element containing mRNAs (Fig 6A) in agreement with
our previously published results (Boczonadi et al, 2014).
Unlike previously seen in zebrafish, none of the transcripts
significantly increased in all three mutant iNPC lines related to
ribosome assembly, rRNA processing, or p53 signalling (Table S6).
Western blotting was performed on total protein from EXOSC3,
EXOSC8, and EXOSC9 patient and control iNPCs, but consistent
with the observed TP53 transcript levels in the RNAseq datasets
(Table S6), p53 protein levels were very variable in the different
control cells, which made it impossible to draw major conclusions
(Fig S5H).
Differential gene expression in developmental pathways in
exosc8 and exosc9 zebrafish mutants
The RNAseq differential expression analysis in zebrafish also showed
significant dysregulation of genes that have previously been asso-
ciated with disease or specific developmental pathways (Table S1).
Down-regulated genes were mostly enriched in metabolic-related
GO terms, with a few significantly down-regulated genes enriched in
the terms cerebellum and ventral spinal cord development (Fig 2A
and Table S1). In the exosc8 and exosc9 homozygous mutant em-
bryos, there was a 0.33-fold and 0.42-fold reduction in cbln8 (cer-
ebellin 8) mRNA, respectively (Fig 2F). This was also confirmed via
qRT-PCR (Fig 2G). Cerebellins are a family of adhesion molecules
essential in the formation and function of synapses, especially in the
Purkinje cells (Ito-Ishida et al, 2008; Uemura et al, 2010; Lee et al,
2012). Although nothing is known about the specific function of cbln8,
its reduction could possibly impair the formation of synapses and
influence the development of the cerebellum in the exosc8 and
exosc9 mutant embryos.
In the exosc8 and exosc9 homozygous mutant embryos, there
was a significant reduction in the expression of otx2b (ortho-
denticle homeobox 2, 0.56-fold, and 0.68-fold in the RNAseq data
and 0.40 fold and 0.47 fold via qRT-PCR, respectively). OTX2 is a
transcription factor expressed in the brain and has roles in
midbrain–hindbrain boundary formation during development
(Simeone et al, 1992; Ang et al, 1994; Kurokawa et al, 2012). Mutations
inOTX2 in humans have been associated with otocephaly and other
craniofacial abnormalities that are reliably phenocopied in mouse
and zebrafish models (Matsuo et al, 1995; Chassaing et al, 2012).
Notably, ribosome biogenesis defects have also been linked to
craniofacial abnormalities in humans and in animalmodels (Calo et
al, 2018). To investigate the craniofacial structure in the exosc8 and
exosc9 homozygous mutant zebrafish, we performed Alcian blue
staining to visualise cartilage in the larvae. Alcian blue staining at 5
dpf illustrated abnormal cartilage development in the exosc8 and
exosc9 homozygous mutant embryos (Fig 7A). Both the exosc8 and
exosc9 homozygous mutants had a significantly shorter ceratohyal,
a pharyngeal arch cartilage component, than wild-type and het-
erozygous clutchmates (Fig 7B). The angle of the ceratohyal was
Figure 4. exosc8 and exosc9 homozygous mutant zebrafish have increased
apoptosis.
(A) Acridine orange staining performed on 48-hpf wild-type, exosc8 homozygous
mutant and exosc9 homozygous mutant zebrafish embryos. Representative
images of each category are shown here. Four different clutches of offspring
with 24 embryos each have been analysed; the acridine orange staining has been
performed and evaluated first (without knowledge of the genotype), followed by
genotyping of all embryos that were stained. Scale bar: 500 μm. (B)
Quantification of acridine orange positive spots. Spots were counted in 36 images
of wild-type or heterozygous embryos and 18 images of homozygous mutant
embryos. Bright spots in the yolk sac were not counted. Error bars represent the
standard error (±SEM) and statistical analysis was performed using the unpaired
t test. ****P < 0.0001.
Exosome in pontocerebellar hypoplasia Müller et al. https://doi.org/10.26508/lsa.202000678 vol 3 | no 8 | e202000678 7 of 17
often hyperpolarized in the exosc8 homozygous embryos, mani-
festing in a significantly greater angle when than clutchmates (Fig
7C). The distance between Meckel’s cartilage, and the ceratohyal
was significantly reduced in the exosc9 homozygote embryos (Fig
7D). These are observations which have previously been observed
in zebrafish models of craniofacial abnormalities (Noack Watt et al,
2016).
Discussion
Here, we have established zebrafish models for PCH caused by
mutations in EXOSC8 and EXOSC9, which recapitulate the clinical
phenotype observed in patients with underdevelopment of the
cerebellum and neuromuscular defects. The head and brain size
measurements might indicate that exosc9 mutant fish have a
slightly milder phenotype than exosc8 mutants. Neuromuscular
junctions, however, are slightly more affected in exosc9 mutants
(Fig S3), and both mutants die at the same developmental stage.
Currently, it is difficult to compare disease severity in patients with
EXOSC8 mutations versus EXOSC9 mutations as there is only a very
small number of patients reported. It might be possible that EXOSC9
patients havemilder clinical symptoms than EXOSC8 patients, but it
may also depend on the exact mutation. For EXOSC3 mutations,
where many more patients have been reported, a clearer
genotype–phenotype comparison has shown that certain EXOSC3
mutations are associated with milder symptoms and better survival
rates (Ivanov et al, 2018).
The exosc8 and exosc9 mutant fish also have a slightly milder
phenotype than our previously published exosc8 morphants
(Boczonadi et al, 2014) and the exosc9 morphants and crispants
(Burns et al, 2018). For morpholino-mediated knockdown, studies
have shown that the morphant phenotype is more severe than the
Figure 5. RNAi-mediated core exosome subunit down-regulation in HCT116 cells leads to a 5S RNP-dependent increase in p53 protein levels and a G2/M cell cycle
arrest.
(A) HCT116 cells were treated with siRNAs targeting the EXOSC8 or EXOSC9 mRNA or a control siRNA targeting firefly luciferase for 60 h. Protein levels were analysed by
immunoblotting using antibodies specific for EXOSC8 or EXOSC9 (left panel), p53 (right panel) or karyopherin as loading control (both panels) and at least three
independent repeat experiments were quantified using ImageQuant (GE Healthcare) software. (B) HCT116 cells were treated with siRNAs targeting EXOSC9 and/or core
5S RNP component RPL5mRNA or a control siRNA targeting firefly luciferase for 60 h. Protein levels were analysed by immunoblotting using antibodies specific for EXOSC9
(upper panel), p53 (middle panel), or karyopherin as loading control (lower panel), and at least three independent repeat experiments were quantified using ImageQuant
(GE Healthcare) software. (C, D) Cell cycle analysis was performed using the FACS Canto II flow cytometer and evaluated using FACSDIVA software. (B) Following
actinomycin D (ActD, 4 nM, 18 h) or siRNA treatment (as in panel B), the cells were fixed using 70% ethanol, and DNAwas stained using propidium iodide. (C) Representative
profiles are shown in panel (C). (D) The graph in panel (D) shows the average percentage levels of G0/G1 (dark grey), S (light grey), or G2/M (grey) phase of at least three
experimental repeats. (A, B, D) Error bars represent the standard error (±SEM), and statistical analysis was performed using unpaired t tests. Comparison of significance
was performed against the respective control knockdown as indicated or against the plain HCT116 cells for ActD treatment. Absence of significance values indicates no
significant differences to the control. *P-value < 0.05, **P-value < 0.01, ***P-value < 0.001.
Source data are available for this figure.
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genetic mutant phenotype because there are some compensatory
effects by other genes that become up-regulated and rescue the
phenotype (Rossi et al, 2015). This might also be the case for the
crispants, although it has not been studied yet. Some F0-injected
crispants could show a more severe phenotype because of the
injection process of RNA and Cas9. Furthermore, F0 fish might
contain mutations in other genes caused by the guideRNA
binding to other genomic sites; those are removed by
Figure 6. EXOSC3, EXOSC8, and EXOSC9 mutant–induced neuronal
progenitor cells (iNPCs) have alterations in non-coding RNA
expression that correlate with zebrafish mutants.
Summary of RNAseq performed on iNPCs converted from fibroblasts
carrying either EXOSC3, EXOSC8, or EXOSC9mutations or controls. (A)
Log2 ratios of cumulative, normalised RNA read counts for different
non-coding RNA types in EXOSC3, EXOSC8, or EXOSC9 mutant iNPCs
versus the average of controls. (B) Gene set over-representation
analysis of RNAs that showed a significant difference in expression
between EXOSC8 versus control iNPCs. (C) Volcano plot showing the
differential expression of transcripts in EXOSC3, EXOSC8, and EXOSC9
mutant iNPCs versus controls, with statistical significance (P-value) on
the y-axis versus the magnitude of change (fold change) on the x-axis.
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outcrossing in later generations. However, we emphasize that
also in our earlier study (Burns et al, 2018), exosc9 crispants have
a predominantly mild phenotype (only 16% have a moderate or
severe phenotype).
RNAseq analysis performed in the exosc8 and exosc9 mutant
zebrafish shows that levels of mRNAs encoding ribosome biogenesis
factors and several non-coding RNA species are increased. In addition,
we observed increased apoptosis of brain cells, correlating with higher
p53 transcript levels in the mutants. The increase in p53 mRNA levels
was also confirmed in muscle tissue from patients. In addition, p53
protein levels were found increased in a human cancer cell line when
EXOSC8 or EXOSC9 were down-regulated using siRNA. Our analysis
links exosome deficiency to defects in ribosome production, which, in
turn, affect p53-dependent cellular signalling pathways. Inherited
diseases caused by exosome subunit mutations could, therefore, be
considered as ribosomopathies caused by ribosome dysfunction.
Work carried out by other groups showed that the knockdown of
EXOSC3 or the exosome-associated 39-59 exonucleases DIS3 and
EXOSC10/RRP6 in mammalian cell lines had profound consequences
on the levels of many different RNA types: Ablation of EXOSC3 and
EXOSC10 in mouse embryonic stem (ES) cells (Pefanis et al, 2015)
resulted in increased levels of long non-coding RNAs, antisense
RNAs, and enhancer RNAs compared with wild-type control ES cell
transcriptomes. Knockdown of EXOSC3 by siRNA in mammalian cells
was also shown to result in an enrichment of snoRNA precursors
where introns had not been removed and of PROMoter uPstream
Transcripts (PROMPTs) (Lubas et al, 2015). In agreement with these
studies, we also detected increased levels of lincRNAs and snoRNAs
in the iNPC from exosome patients. However, we did not observe
clearly elevated levels of PROMPTs in our samples, except for a slight
increase in read counts upstream of the transcription start site in the
EXOSC8 iNPC line, and to a lesser extent in EXOSC3 and EXOSC9 lines
at 77 genes (Fig S9). The total number of reads in these regions was
very low in general though, making the results unreliable. The lack of
PROMPT accumulation might be due to different RNA isolation and
analysis techniques compared with the published studies.
Figure 7. exosc8 and exosc9 homozygous mutant
zebrafish develop craniofacial abnormalities.
(A) Alcian blue staining in 5-dpf wild-type, exosc8
homozygous mutant, and exosc9 homozygous mutant
zebrafish embryos. Scale bar: 500 μm. (B, C, D) Length
of ceratohyal, (C) angle of ceratohyal, and (D) distance
from Meckel’s cartilage to the ceratohyal in exosc8
homozygous mutant and exosc9 homozygous mutant
zebrafish embryos. (B, C, D) 13 control, 18 exosc8
(c.26_27del), and 14 exosc9 (c.198_208del) homozygous
larvae were measured for the quantification in (B, C,
D). Error bars represent the standard error (±SEM), and
statistical analysis was performed using unpaired t tests
(exosc8 versus wt and exosc9 versus wt, respectively).
The difference between mutant and wt is not
significant where no P-value is given. Abbreviations: CH,
ceratohyal; M, Meckel’s cartilage.
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EXOSC3, EXOSC8, EXOSC9, EXOSC10, or DIS3 depletion causes the
appearance of mis-processed 5.8S pre-rRNA species and accu-
mulation of larger rRNA precursors (Tomecki et al, 2010; Lubas et al,
2011; Tafforeau et al, 2013; Sloan et al, 2013b, 2014; Kobylecki et al,
2018; Davidson et al, 2019). Moreover, a recent study showed that
neurological disease–associated mutations of EXOSC3 indeed
caused pre-rRNA processing defects when introduced into Rrp40,
the EXOSC3 homologue in budding yeast (Gillespie et al, 2017).
Likewise, HITS-CLIP (high-throughput sequencing of RNA isolated
by cross-linking immunoprecipitation) identified (pre-)rRNAs as
major targets of the human exosome (Belair et al, 2019). In line with
these publications, one of the main findings of our RNAseq analysis
was that one-third of all increased protein-coding transcripts relate
to ribosome assembly and rRNA processing; furthermore, we ob-
served an increase in the levels of scaRNAs and snoRNAs, which are
important for pre-rRNA processing and modification (Watkins &
Bohnsack, 2012). Up-regulation of RNA and protein factors im-
portant for key steps during ribosome synthesis might, therefore, be
a compensation mechanism for a defect in rRNA processing caused
by exosome deficiency.
Defects in the assembly of the ribosome cause ~20 distinct
genetic diseases known as ribosomopathies (reviewed in Aubert et
al [2018]). Like the exosome, the ribosome is highly abundant and
ubiquitously expressed, yet ribosomopathies are characterised by
cell- and tissue-specific defects due to improper cellular devel-
opment and cell death, such as anaemia and skeletal defects (e.g.,
Diamond–Blackfan anaemia), craniofacial defects (Treacher Collins
syndrome) or microcephaly (Bowen–Conradi syndrome). Moreover,
patients with ribosomopathies are often pre-disposed to cancer
because of misregulation of p53 and downstream signalling
pathways, which affect the cell cycle and cellular survival. RNAi-
mediated knockdown of EXOSC8 or EXOSC9 in HCT116 cells resulted
in stabilisation of the p53 protein, which, in the case of EXOSC9, was
demonstrated to be alleviated by co-depletion of the 5S RNP
component RPL5. This indicated that the impact of core exosome
depletion on p53-dependent signalling is not just due to increased
levels or stability of the p53 mRNA, as seen in our mutant zebrafish
and patient muscle samples, but also linked to the essential
function of the exosome in the processing of the rRNA. Although
future studies will dissect the multiple ways by which p53 levels
may be affected in the absence of a functional core exosome, and to
what extent this is carried out at themRNA and/or protein level, our
data strongly suggest that diseases characterised by exosome
deficiencies should also be considered as ribosomopathies. Fur-
thermore, EXOSC9 depletion also caused a G2/M cell cycle arrest
reminiscent of a nucleolar stress response, which may slow down
cell proliferation and eventually lead to apoptosis, consistent with
the phenotype seen in the zebrafish model.
Embryos with homozygous exosc8 and exosc9mutations develop
a small head, and have less brain tissue, and a smaller cerebellum.
Acridine orange staining showed that there was increased apo-
ptosis in the mutant embryos, supported also by RNAseq and qRT-
PCR findings, suggesting that elevated rates of cell death in the
brain play a key role in pathogenesis of exosome mutations. We
tried to rescue the increased cell death in the brain of exosc8 and
exosc9 mutant fish by injecting an anti-p53 morpholino oligonu-
cleotide at the one-cell stage and monitored the head size at 5 dpf;
however, it turned out that injecting the p53 morpholino into wild-
type fish led to a decreased head size itself, making the phenotype
rescue impossible (data not shown).
We also observed that exosc8 and exosc9 homozygous mutant
embryos develop craniofacial abnormalities. In patients with
exosome subunit mutations, craniofacial abnormalities have only
been reported in patients with EXOSC2 mutations (Di Donato et al,
2016). However, a very recent publication also reported EXOSC9
patients with facial dysmorphic features (Bizzari et al, 2019), indi-
cating that the disease spectrum could be overlapping. As the
number of reported patients with exosome mutations is not very
high, the full spectrum of disease symptoms might not be known
yet.
Craniofacial defects are common in ribosomopathies: both
Treacher Collins syndrome and Diamond–Blackfan anaemia
present with craniofacial hypoplasia (Ross & Zarbalis, 2014). Various
studies have demonstrated that mutations in nucleolar proteins
involved in rRNA synthesis or ribosomal subunit assembly affect
ribosome biogenesis and activate a p53 response through a
nucleolus-mediated stress (Ross & Zarbalis, 2014). Cranial neural
crest cells, which form bone, cartilage, and connective tissue in the
head, are especially sensitive to nucleolar stress (Ross & Zarbalis,
2014; Calo et al, 2018). Ribosome assembly defects might leave
neural crest cells unable to produce essential new proteins re-
quired for their developmental programme or migration (Calo et al,
2018). For example, zebrafish with mutations in 18S rRNA factor 1
(esf1) have severe pharyngeal cartilage loss due to deficits in
cranial neural crest cell development (Chen et al, 2018). Esf1 mu-
tants also show increased apoptosis and p53 signalling. Similarly,
mutations in zebrafish Wdr43, another ribosome biogenesis factor,
also result in cartilage loss due to neural crest cell defects (Zhao et
al, 2014). The cartilage defects seen in exosc8 and exosc9 mutants
are, therefore, likely due to neural crest cell development defects.
Both esf1 and Wdr43 transcripts are among the increased ribosome
biogenesis factors in our mutant zebrafish, suggesting that up-
regulation of these proteins may contribute to the previously
suggested mechanism to compensate for defects in rRNA pro-
cessing caused by exosome deficiency. Interestingly, mutations in
pescadillo, another differentially expressed transcript in our
mutant zebrafish, disrupt oligodendrocyte formation and cause a
loss of myelination in zebrafish (Simmons & Appel, 2012). Pes-
cadillo is required for nucleolar assembly and ribosome bio-
genesis (Lerch-Gaggl et al, 2002); its loss affects cell cycle
progression and migration of oligodendrocytes in zebrafish em-
bryos. We have previously shown that exosc8 morphant zebrafish
and patients with EXOSC8 mutations had myelination defects
(Boczonadi et al, 2014), which might also relate to a perturbation
of ribosome biogenesis.
Transcripts encoding ribosome biogenesis factors were not
differentially expressed in iNPCs derived from patient fibroblasts,
suggesting that, in contrast to our mutant zebrafish, iNPCs do not
alter gene expression to compensate for defects in rRNA pro-
cessing caused by exosome deficiency. We found, however, a
dysregulation of scaRNAs and snoRNAs in iNPCs, which are es-
sential for co- and post-transcriptional 29-O-methylation of rRNA,
snRNA, and tRNA (Meier, 2017). Notably, some snoRNAs are es-
sential for pre-rRNA processing (Watkins & Bohnsack, 2012).
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Dysregulation of scaRNAs and snoRNAs in the iNPCs may,
therefore, also directly and/or indirectly affect rRNA processing
and ribosome assembly. Mutations in Essential for Mitotic Growth
1 (EMG1), a ribosome biogenesis factor involved in the maturation
of the 18S rRNA, cause the ribosomopathy Bowen–Conradi syn-
drome (Armistead et al, 2009, 2014). EMG1 mutations only caused
cell cycle arrest in fast proliferating lymphoblasts, but not in
slowly proliferating fibroblasts (Armistead et al, 2014). This pub-
lication indicates that the extent of manifestation of a ribosome
biogenesis defect, and, consequently, its downstream effects on
gene expression and cellular signalling, greatly depends on the
proliferation rate of the cells.
In addition, the residual amount of functional exosome complex
still present in our patient cells might be higher than in the siRNA-
induced depletion in the studies mentioned above, thus explaining
the less striking changes in transcript levels detected in our patient
cells. A recent publication has shown that the exosome is down-
regulated when ES cells start to differentiate and up-regulated
when fibroblasts are reprogrammed to induced pluripotent stem
cells (Belair et al, 2019). As the experimental setup for the con-
version of fibroblasts to iNPCs relies on similar mechanisms as the
reprogramming to induced pluripotent stem cells, presumably the
exosome is also up-regulated during the conversion performed by
us. Residual amount of exosome might be enough to prevent a
severe impairment of ribosome biogenesis in iNPCs. Furthermore,
cellular environment and growth factor signalling are different in
cell culture compared with the in vivo context; cellular require-
ments change dramatically once cells differentiate or migrate
during development. The discrepancies between our results in
cultured patient cells and zebrafish models for exosome-related
diseases emphasize the importance of animal models to study
these complex diseases.
Zebrafish models have also been generated for other PCH
subtypes, such as PCH caused by mutations in CLP1, TOE1, and
tsen54. Clp1 zebrafish mutants had an abnormal head shape, im-
paired movement abilities, and died before 5 dpf (Schaffer et al,
2014). Morpholino-induced knockdowns of toe1 and tsen54 in
zebrafish led to a phenotype with small heads, small eyes, curved
tails, and structural defects of the developing midbrain, cerebel-
lum, and hindbrain (Kasher et al, 2011; Lardelli et al, 2017). Fur-
thermore, Clp1 mutants and tsen54 morphants also had increased
cell loss in the forebrain and hindbrain, leading to decreased levels
of themidbrain marker otx2 from 48 hpf onwards (Kasher et al, 2011;
Schaffer et al, 2014), as observed in the transcript analysis in our
exosome mutant fish. Although CLP1, TOE1, and the TSEN complex
are not linked to ribosome biogenesis, the similar phenotype in
patients and animal model points towards a converging disease
mechanism in PCH.
In summary, our results provide new insights into the mecha-
nism behind pathogenesis in exosome-related diseases and fur-
ther establish the de-regulation of RNA pools and ribosome
biogenesis as a common disease pathway in PCH andmotor neuron
disorders. Perturbation of RNA levels and ribosome biogenesis
leads to p53 up-regulation, cell cycle arrest, and increased cell
death in the brain. Further research, however, is needed to un-
derstand why certain cell types in the brain are more vulnerable
than others.
Materials and Methods
Zebrafish strains and husbandry
All zebrafish used in this study were the golden strain. All proce-
dures carried out on zebrafish were approved by the Home Office
UK. Zebrafish embryos were collected and raised at 28.5°C in E3
medium using established procedures and staged in hpf or dpf
(Kimmel et al, 1995).
single (s)gRNA synthesis
Crisprscan (Moreno-Mateos et al, 2015) was used to identify a target
site in exon 2 of exosc8 and exon 3 of exosc9 in zebrafish. sgRNA was
produced as described elsewhere (Varshney et al, 2015). An oli-
gonucleotide with a T7 promoter, target sequence, and a com-
plementary sequence was annealed to a bottom strand “ultramer”
oligo in a thermocycler and extension of the oligonucleotides was
catalysed by DNA polymerase (Mytaq) to form the template oli-
gonucleotide for sgRNA synthesis (Table S7). The sgRNA template
oligonucleotide was purified using a QIAGEN PCR purification kit.
sgRNA was synthesised from the sgRNA oligonucleotide template
using the MEGAshortscript T7 Kit (Ambion) and purified with the
mirVana RNA isolation kit (Thermo Fisher Scientific) and stored at
−80°C until required for injection.
Injection of sgRNA/Cas9
The sgRNA was diluted to 300 ng/μl with 2 μM Cas9 protein (New
England Biolabs), 2M KCl and 0.05% phenol red, and heated to 37°C
for 5 min. Freshly laid embryos were injected up until the two-cell
stage with 1 nl of gRNA.
Establishing the exosc8 and exosc9 zebrafish lines
Injected F0mosaic founder fish were raised to adulthood with some
clutchmates euthanized to confirm mutagenesis. To confirm mu-
tagenesis genomic DNA was extracted from pools of 5–10 embryos
per clutch at 5 dpf using the “hotSHOT” technique (Meeker et al,
2007). Embryos were lysed in 20 μl of 50 mM NaOH (Sigma-Aldrich)
for 30 min at 95°C, periodically vortexing. The lysate was then
neutralized with 20 μl 100 mM Tris–HCl (Sigma-Aldrich). PCR was
then performed on the lysates using the primers listed in the
supplementary data. The PCR products were ligated into the pGEM-
T easy vector (Promega) following the manufacturer’s instructions.
JM109 High Efficiency Competent Cells (Promega) were transformed
with the ligated plasmid and plated on ampicillin containing LB
agar plates. Plates were incubated at 37°C overnight. Colony PCR
was then performed on plasmids using standard pUC/M13 primers
(Eurofins, supplementary data). PCR products were sequenced to
confirm that random indels had occurred in the target regions.
Once F0 mosaic zebrafish were of breeding age they were
outcrossed with wild type golden zebrafish to produce the F1
generation of zebrafish. These zebrafish were raised to adulthood
and a biopsy of the tail fin was collected under anaesthesia with
tricaine (140–164 mg/litre). Genomic DNA was extracted using the
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“hotShot” technique (Meeker et al, 2007) and PCR and sequencing
was performed to detect F1 heterozygotes (Fig S1). F1 heterozygous
zebrafish were outcrossed with wild-type golden zebrafish to
produce F2 zebrafish, which were raised and then genotyped when
adults to identify the heterozygotes. These F2 zebrafish were
incrossed to produce embryos used in subsequent studies. Live
embryos were imaged using a Leica MZ16 microscope.
Whole mount immunofluorescence in zebrafish embryos
Zebrafish used for immunofluorescence were treated with 0.003%
1-phenyl-2-thiourea (Sigma-Aldrich) from 24 hpf to prevent pig-
ment formation and aid imaging. Zebrafish embryos were termi-
nally anaesthetized at 5 dpf using tricaine and then fixed overnight
at 4°C in 4% paraformaldehyde in PBS. Embryos were washed in
PBS plus 0.1% Tween 20 (PBT; Sigma-Aldrich) and then per-
meabilized with acetone for 30 min at −20°C. Embryos were also
permeabilized with 0.25% trypsin for 90 min. Embryos were then
blocked in blocking solution (5% horse serum in PBT) for 1 h.
Embryos were incubated in the primary antibodies diluted in the
blocking solution (SV2, 1:200; Developmental Studies Hybridoma
Bank; HuC, 1:200; Abcam; pvalb7 1:1,000) overnight at 4°C. After
washing with PBT, embryos were incubated with secondary anti-
bodies (anti-mouse Alexa Fluor 488, anti-rabbit Alexa Fluor 594, or
anti-rabbit Alexa Fluor 488; Invitrogen) diluted in blocking solution
for 1 h. Phalloidin and α-bungarotoxin (Thermo Fisher Scientific)
were conjugated to Alexa Fluor 594 and did not require any sec-
ondary antibodies. Immunofluorescent images were captured us-
ing a Zeiss Axio Imager with Zen software. The Parvalbumin7
antibody was a kind gift of Prof. Masahiko Hibi, Nagoya University,
Japan.
Alcian blue staining
Zebrafish used for Alcian blue staining were treated with 0.003%
1-phenyl-2-thiourea (Sigma-Aldrich) from 24 hpf to prevent pigment
formation and aid imaging. Zebrafish embryos were terminally
anaesthetized at 5 dpf using tricaine (200–300 mg/ml; Sigma-
Aldrich). Embryos were then fixed overnight at 4°C in 4% parafor-
maldehyde in PBS. Embryos were washed in PBS and then dehy-
drated in 50% ethanol then stained overnight with Alcian blue (0.02%
Alcian blue [Sigma-Aldrich], 60 mM MgCl2 in 70% ethanol). Zebrafish
were washed in PBS and then left for the tissue to clear overnight in
0.25% KOH. Zebrafish were washed in PBS and then imaged using a
Leica stereomicroscope. Image analysis was performed using ImageJ
(Schneider et al, 2012b).
Acridine orange staining
At 48 hpf zebrafish embryos were placed in 5 μl/ml acridine orange
(Sigma-Aldrich) for 30 min and then washed in aquarium water.
Embryos were imaged using a Zeiss Axio Imager with Zen software.
Cell culture
Primary skin fibroblasts of patients carrying the homozygous
p.(Leu14Pro) in EXOSC9, the homozygous p.(Ala2Val) in EXOSC8, the
homozygous p.(Gly31Ala) in EXOSC3, and control fibroblast lines
were grown in high-glucose DMEM (Thermo Fisher Scientific)
supplemented with 10% FBS as previously described in Burns et al
(2018). The patient with the homozygous EXOSC8 mutation (patient
from pedigree 3 in Boczonadi et al [2014]) presented with spinal
muscular atrophy and cerebellar and corpus callosum hypoplasia.
The patient with EXOSC3 mutations suffered from a severe form of
PCH type 1 that included severe hypotonia, weakness, absent motor
and mental development, and signs of neuronal loss in spinal
anterior horns, cerebellum, and parts of the midbrain (Schwabova
et al, 2013). The patient carrying an EXOSC9 mutation (patient 1 in
Burns et al [2018]) presented with muscle weakness, hypotonia,
axonal motor neuronopathy, and mild cerebellar atrophy; in
general, her clinical symptoms were milder than those of patients
with EXOSC8 and EXOSC3 mutations. The control fibroblasts were
obtained from genetically unrelated, healthy adult donors (two
female and one male) aged between 20 and 40 yr.
Direct conversion of skin fibroblasts to iNPCs
Primary fibroblasts of the EXOSC3, the EXOSC8, the EXOSC9 patient
and four control fibroblasts were converted to neuronal progenitor
cells using the method published by Meyer et al (2014), (Fig S5A–F).
Successful conversion was confirmed by gene expression analysis
for neuronal and fibroblast markers where an up-regulation in the
expression of the neural stem cell markers Sox2, Sox1, nestin, and
Pax6 and a down-regulation of the fibroblast markers Col1a1 and
Col3a1 was observed (Fig S5G). One colony was picked from each
iNPC line for further expansion and RNAseq analysis.
RNAi-mediated down-regulation of EXOSC8 or EXOSC9
HCT116 cells were cultured in DMEM (Sigma-Aldrich), supplemented
with 10% FBS (Sigma-Aldrich), and 1% penicillin/streptomycin
(Sigma-Aldrich). RNAi-mediated depletion in HCT116 cells was
performed by reverse transfection of siRNA duplexes targeting the
mRNA sequence of EXOSC8, EXOSC9, or RPL5 using Lipofectamine
RNAiMAX transfection reagent (Life Technologies). An siRNA tar-
geting firefly luciferase mRNA (GL2) was used as a negative control.
Approximately 80,000 cells were seeded in 24-well plates (Sarstedt)
and incubated with the siRNA(s) for ~60 h before being harvested
for protein analysis. The following siRNA oligos were used: control
(GL2): 59-CGUACGCGGAAUACUUCGATT (Elbashir et al, 2002); EXOSC8:
59-CGACUACGAUGGAAACAUUTT, EXOSC9: 59-GCUACUAAAAGAUCAA-
GUUTT (both from Tafforeau et al [2013]); RPL5: 59-GGUUGGCCU-
GACAAAUUAUTT. All siRNA oligos were obtained from Eurofins MWG.
SDS–PAGE and immunoblotting
HCT116 cells grown in 24-well plates were pelleted by centrifugation
and resuspended in ~50 μl of 2× protein loading dye (75 mM
Tris–HCl, pH 6.8, 1.25 mM EDTA, 20% glycerol, 2.5% SDS, 0.125%
bromophenol blue, and 50 mM DTT). 10 μl of each sample was
loaded on a 1.5 mm denaturing SDS 13% polyacrylamide gel (Bio-
Rad), transferred to a nitrocellulose membrane (Protran; GE
Healthcare) and probed with monoclonal primary antibodies
recognising EXOSC8, EXOSC9, p53, karyopherin β1, or GAPDH, diluted
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in PBS-Triton X-100 (0.1%, vol/vol) containing 2% non-fat dried milk
(wt/vol) (Marvel). An IRDye-labelled secondary antibody (LI-COR)
was used, and membranes were visualised using the Odyssey LI-
COR system (LI-COR). Quantification was performed using Image-
Quant software (GE Healthcare) and quantified protein levels were
normalised to levels of the loading control, karyopherin. The fol-
lowing antibodies were used: α-EXOSC8 (mouse, (H-8) sc- 393027;
Santa Cruz), dilution 1:1,000; α-EXOSC9 (mouse, (D-6) sc-271815;
Santa Cruz), dilution 1:1,000; α-p53 (mouse, (DO-1) sc-126; Santa
Cruz), dilution 1:500; α-karyopherin β1 (mouse, (H-7) sc-137016;
Santa Cruz), dilution 1:2,000; α-GAPDH (mouse, (0411) sc-47724;
Santa Cruz), dilution 1:10,000; and secondary antibody Donkey
α-Mouse 800CW LI-COR (926-32212), dilution 1:10,000.
PI staining and flow cytometry
After 60-h siRNA-mediated depletion of EXOSC9 or overnight (18 h)
actinomycin D (ActD, 4 nM) treatment, HCT116 cells were pelleted by
centrifugation, washed in PBS containing 1% FBS, and fixed in ice-
cold 70% ethanol. Fixed cells were resuspended in RNase A (Sigma-
Aldrich) diluted in water (100 μg/ml). PI (Invitrogen), diluted in PBS,
was added to a final concentration of 50 μg/ml. Cells, in a total
volume of 250 μl, were incubated in the dark for 20 min at 4°C
before analysis by flow cytometry using the FACS Canto II machine
and analysed using FACSDIVA software (BD Biosciences).
RNA extraction
RNA from cultured cells or zebrafish was extracted with Trizol re-
agent (Thermo Fisher Scientific) following the manufacturer’s in-
structions. RNA extraction was followed by DNAse treatment with
the DNA-free DNA Removal Kit (Ambion).
For downstream RNAseq analysis, RNA from cells and zebrafish
embryos was extracted using the mirVana miRNA isolation kit
(Thermo Fisher Scientific) following the manufacturer’s instruc-
tions. Embryos were euthanised at 5 dpf in tricaine before RNA
extraction. Pools of ~30 embryos per experimental group were
collected. RNA extraction for RNAseq analysis was performed in
triplicate for each sample (i.e., three cell pellets or three zebrafish
embryo pools). Three biological replicates for each mutant and for
the controls (3 batches of 30 pooled embryos each) were used for
the RNA analysis.
RNA sequencing
RNAseq libraries were prepared with Illumina TruSeq Stranded polyA–
enriched RNA with Ribo-Zero Human kit and sequenced as previously
described (Burns et al, 2018). Exosc3 morphant zebrafish and control
zebrafish RNAseq reads were downloaded from European Nucleotide
Archive Study: PRJNA470927 (Francois-Moutal et al, 2018). Raw sequence
reads were trimmed to 50 bp with FastX-toolkit v.0.0.14 (http://
hannonlab.cshl.edu/fastx_toolkit/index.html) and aligned to complete
zebrafish (danRer11) or human (hg38) reference genomes, using the STAR
aligner v.2.5.3a two-pass protocol (Dobin et al, 2013). Differential ex-
pression analysis was performed with HTSeq v.0.9.1 (Anders et al, 2015)
and DESeq2 v.1.12.4 (Love et al, 2014). Gene set over-representation
analysis was performed via http://cpdb.molgen.mpg.de/. Bedfiles of
non-coding RNA typeswere prepared from gene coordinates available at
Ensembl Biomart except for cytosolic tRNAs, where sequences and co-
ordinates were obtained from GtRNAdb (http://gtrnadb.ucsc.edu/).
BEDTools v.2.26.0 was used to obtain per gene strand–specific counts of
non-coding RNAs. RNA sequencing files were deposited to National
Center for Biotechnology Information Gene Expression Omnibus under
accession number GSE151452.
RNAseq data from muscle samples of two EXOSC9 patients has
been published previously (Burns et al, 2018).
qRT-PCR
To confirm the RNAseq results, quantitative real-time PCR (qRT-
PCR) was carried out using a CFX96 RealTime qPCR machine (Bio-
Rad). The SuperScript III First-Strand Synthesis System (Thermo
Fisher Scientific) was used to produce cDNA from 1 μg of the iso-
lated RNA following the manufacturer’s instructions. qRT-PCR was
performed using the primers listed in the supplementary data using
iTaq Universal SYBR Green Supermix (Bio-Rad). Each reaction was
carried out in triplicate and elongation factor 1 alpha (ef1α,
zebrafish) or GAPDH (human cells) was selected as an internal
control to normalize the RNA levels. The 2−ΔΔCt method was used to
quantify gene expression. Three biological replicates for each
mutant and for the controls (3 batches of 30 pooled embryos each)
were used for the RNA analysis.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202000678.
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